NEW YORK (GenomeWeb News) – Waters today reported a 2 percent decline year over year in revenues for the first quarter, missing Wall Street estimates on the top and bottom line.

For the three months ended March 31, the company posted $420.5 million in total revenues, down from $427.6 million a year ago, and short of consensus analyst estimates of $441.8 million. Foreign currency translation reduced sales growth by 2 percent, Waters said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.